Transgene announces License Option Exercise by AstraZeneca for an Oncolytic Virus Generated by Transgene's Invir.IO™ Platform

Press release content from Business Wire. The AP news staff was not involved in its creation.

Related Keywords

United States ,Paris ,France General ,France ,United Kingdom ,Lucie Larguier ,Ben Brahim ,Transgene Euronext ,Sylvie Berrebi ,Astrazeneca ,Twitter ,Corporate Communications ,European Society For Medical Oncology ,Nasdaq ,Euronext Paris ,Vaccinia Virus ,European Society ,Medical Oncology ,Artificial Intelligence ,Risk Factors ,Universal Registration Document ,Business Wire ,Technology ,Health ,Business ,Cancer ,Europe ,Transgene ,